Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma
Clinical trial NCT03084640 · COMPLETED
Trial details
- NCT number
- NCT03084640
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2021-07-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.